MET is a RTK involved in cell growth, replication, and motility, that could play a role in tumorigenesis of several human cancers through multiple mechanisms, including altered regulation, genetic mutations, and upregulation of its ligand hepatocyte growth factor (HGF) [13]. This evidence concerns the gene MET and cancer.